Nippon Chemiphar Co., Ltd. (4539.T)
JPY 1512.0
(-0.13%)
JPY 1512.0
(-0.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 49.54 Billion JPY | 2.01% |
| 2022 | 48.57 Billion JPY | -1.78% |
| 2021 | 49.45 Billion JPY | 4.94% |
| 2020 | 47.12 Billion JPY | 2.75% |
| 2019 | 45.86 Billion JPY | -2.27% |
| 2018 | 46.92 Billion JPY | 0.24% |
| 2017 | 46.81 Billion JPY | -0.4% |
| 2016 | 47 Billion JPY | 7.69% |
| 2015 | 43.64 Billion JPY | 5.35% |
| 2014 | 41.42 Billion JPY | 3.3% |
| 2013 | 40.1 Billion JPY | 13.01% |
| 2012 | 35.48 Billion JPY | 5.03% |
| 2011 | 33.79 Billion JPY | 9.76% |
| 2010 | 30.78 Billion JPY | 4.01% |
| 2009 | 29.6 Billion JPY | 19.86% |
| 2008 | 24.69 Billion JPY | 13.47% |
| 2007 | 21.76 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 51.03 Billion JPY | 2.99% |
| 2024 Q2 | 52.02 Billion JPY | 1.95% |
| 2023 FY | 49.54 Billion JPY | 2.01% |
| 2023 Q2 | 50.87 Billion JPY | -2.32% |
| 2023 Q4 | 49.54 Billion JPY | -2.74% |
| 2023 Q1 | 52.07 Billion JPY | 7.22% |
| 2023 Q3 | 50.94 Billion JPY | 0.14% |
| 2022 Q2 | 50.65 Billion JPY | -1.45% |
| 2022 Q1 | 51.4 Billion JPY | 3.94% |
| 2022 Q3 | 50.03 Billion JPY | -1.23% |
| 2022 FY | 48.57 Billion JPY | -1.78% |
| 2022 Q4 | 48.57 Billion JPY | -2.93% |
| 2021 Q3 | 50.63 Billion JPY | 4.33% |
| 2021 FY | 49.45 Billion JPY | 4.94% |
| 2021 Q1 | 48.12 Billion JPY | 2.13% |
| 2021 Q2 | 48.53 Billion JPY | 0.84% |
| 2021 Q4 | 49.45 Billion JPY | -2.32% |
| 2020 Q2 | 46.93 Billion JPY | -1.62% |
| 2020 Q1 | 47.7 Billion JPY | 4.02% |
| 2020 Q3 | 48.05 Billion JPY | 2.4% |
| 2020 FY | 47.12 Billion JPY | 2.75% |
| 2020 Q4 | 47.12 Billion JPY | -1.95% |
| 2019 Q1 | 48.58 Billion JPY | 3.54% |
| 2019 Q2 | 47.32 Billion JPY | -2.61% |
| 2019 FY | 45.86 Billion JPY | -2.27% |
| 2019 Q4 | 45.86 Billion JPY | -3.54% |
| 2019 Q3 | 47.54 Billion JPY | 0.47% |
| 2018 Q2 | 47.14 Billion JPY | -0.96% |
| 2018 Q3 | 47.66 Billion JPY | 1.09% |
| 2018 FY | 46.92 Billion JPY | 0.24% |
| 2018 Q4 | 46.92 Billion JPY | -1.55% |
| 2018 Q1 | 47.6 Billion JPY | 1.69% |
| 2017 Q1 | 48.59 Billion JPY | 3.39% |
| 2017 Q4 | 46.81 Billion JPY | -1.73% |
| 2017 Q3 | 47.63 Billion JPY | 3.2% |
| 2017 Q2 | 46.16 Billion JPY | -5.01% |
| 2017 FY | 46.81 Billion JPY | -0.4% |
| 2016 Q1 | 44.31 Billion JPY | 1.54% |
| 2016 Q4 | 47 Billion JPY | 3.2% |
| 2016 Q3 | 45.54 Billion JPY | 4.63% |
| 2016 Q2 | 43.53 Billion JPY | -1.77% |
| 2016 FY | 47 Billion JPY | 7.69% |
| 2015 Q3 | 43.54 Billion JPY | 3.87% |
| 2015 FY | 43.64 Billion JPY | 5.35% |
| 2015 Q4 | 43.64 Billion JPY | 0.22% |
| 2015 Q2 | 41.92 Billion JPY | -1.89% |
| 2015 Q1 | 42.73 Billion JPY | 3.15% |
| 2014 Q2 | 41.59 Billion JPY | -4.09% |
| 2014 Q4 | 41.42 Billion JPY | -2.0% |
| 2014 FY | 41.42 Billion JPY | 3.3% |
| 2014 Q3 | 42.27 Billion JPY | 1.64% |
| 2014 Q1 | 43.36 Billion JPY | 8.13% |
| 2013 Q2 | 39.21 Billion JPY | 2.77% |
| 2013 Q3 | 41.02 Billion JPY | 4.62% |
| 2013 Q4 | 40.1 Billion JPY | -2.24% |
| 2013 FY | 40.1 Billion JPY | 13.01% |
| 2013 Q1 | 38.15 Billion JPY | 7.52% |
| 2012 Q1 | 37.6 Billion JPY | 11.3% |
| 2012 Q3 | 36.64 Billion JPY | -2.91% |
| 2012 Q2 | 37.74 Billion JPY | 0.37% |
| 2012 FY | 35.48 Billion JPY | 5.03% |
| 2012 Q4 | 35.48 Billion JPY | -3.16% |
| 2011 Q1 | 33.9 Billion JPY | 10.13% |
| 2011 Q4 | 33.79 Billion JPY | 0.09% |
| 2011 FY | 33.79 Billion JPY | 9.76% |
| 2011 Q3 | 33.76 Billion JPY | 1.72% |
| 2011 Q2 | 33.18 Billion JPY | -2.11% |
| 2010 Q3 | 31 Billion JPY | 0.77% |
| 2010 Q4 | 30.78 Billion JPY | -0.69% |
| 2010 FY | 30.78 Billion JPY | 4.01% |
| 2010 Q1 | 30.79 Billion JPY | 4.03% |
| 2010 Q2 | 30.76 Billion JPY | -0.1% |
| 2009 Q2 | 27.14 Billion JPY | 0.0% |
| 2009 Q4 | 29.6 Billion JPY | -3.57% |
| 2009 Q3 | 30.69 Billion JPY | 13.09% |
| 2009 FY | 29.6 Billion JPY | 19.86% |
| 2008 Q3 | 24.01 Billion JPY | 0.0% |
| 2008 Q4 | 24.69 Billion JPY | 2.83% |
| 2008 FY | 24.69 Billion JPY | 13.47% |
| 2007 FY | 21.76 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -35.477% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 99.672% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 94.54% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 96.503% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -221.301% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 81.189% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 71.13% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 96.445% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -188.355% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 84.93% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | 68.798% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | 35.197% |
| Tsumura & Co. | 428.25 Billion JPY | 88.43% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 81.011% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | 62.866% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 88.495% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | 41.935% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | 67.085% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | 72.114% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -229.31% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | 36.238% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -222.745% |
| MedRx Co., Ltd | 2.05 Billion JPY | -2314.62% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -161.49% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -1843.059% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -2345.698% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | 46.901% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 87.03% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -1075.569% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 93.594% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -54.818% |